Literature DB >> 9683951

Congenital-onset central chorioretinal dystrophy associated with high myopia.

M Iqbal1, I K Jalili.   

Abstract

We describe six siblings of a 12-member sibship affected with a macular dystrophy that is congenital in onset and is associated with progressive myopia. The age of these siblings ranged from 7 months to 19 years. The presenting feature was visual impairment and the best corrected visual acuity ranged between 1/60 and 6/36. Myopia ranged from -3.00 dioptres in the youngest to -10.50 dioptres in the second-eldest member. The macular lesions in our patients are characterised by a well-defined area of atrophy of choriocapillaris and retinal pigment epithelium. These lesions progressed with age in both size and depth. The extent of choroidal involvement in the lesions varied from only loss of superficial vasculature to sparing of large choroidal vessels as confirmed by fundus fluorescein angiography. One patient also exhibited bilateral Duane's syndrome (type III) and right unilateral ptosis. To the best of our knowledge such a fully established macular lesion presenting at the age of 6 months and associated with progressive myopia has never been described in literature.

Entities:  

Mesh:

Year:  1998        PMID: 9683951     DOI: 10.1038/eye.1998.61

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  3 in total

1.  The ateliotic macula: a newly recognized developmental anomaly.

Authors:  M E De Pool; H el-Hileli; I H Maumenee
Journal:  Trans Am Ophthalmol Soc       Date:  2001

2.  Congenital high myopia and central macular atrophy: a report of 3 families.

Authors:  S Hull; A Kalhoro; J Marr; D A Thompson; G E Holder; A G Robson; A T Moore
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

3.  Homozygosity mapping and whole exome sequencing reveal a novel homozygous COL18A1 mutation causing Knobloch syndrome.

Authors:  Alireza Haghighi; Amit Tiwari; Niloofar Piri; Gudrun Nürnberg; Nasrollah Saleh-Gohari; Amirreza Haghighi; John Neidhardt; Peter Nürnberg; Wolfgang Berger
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.